Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QP001 Injection for Postoperative Abdominal Pain
CTR20222714Phase 3Completed
- Sponsor
- Nanjing Delova Biotech Co., Ltd.
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of QP001 in postoperative pain, sponsored by Nanjing Delova Biotech Co., Ltd.. Started Oct 2022; status: completed.
02
Drugs
QP001
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20222714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222714.